How Healthcare Will Navigate Virtual Hiring Longterm

 

Prior to March of 2020, Oliver Esman, Managing Partner, Strawn Arnold & Associates did the vast majority of his recruiting work face to face. Today, Esman reports that 95% of their recruiting work is done virtually. “I spend my life on Teams and Zoom and FaceTime and people are adapting to it. You know, I think before people were worried that they were missing something on a virtual interview, missing the personality, not getting all the information, really getting a true sense of the candidate. And that’s just people have gotten more comfortable with doing things virtually,” Esman said.

Esman shared a few tips to make recruiting from a distance feel more natural and productive. First, he recommends studying the candidate’s resume in advance so you feel more comfortable. “So that’s really the key to it, you know studying a resume in advance and so you’re comfortable, you’re prepared. That makes a difference, because the candidate on the other end is ready to answer questions,” Esman explained. He also suggests getting comfortable with technology as you’ll be using it a lot.

Esman acknowledges you do lose some of the perks of in person interviews and that sometimes asking extra questions is necessary to make up for these disadvantages. For example, being willing to ask probing questions because you can’t take in their body language like you would during a face to face interview. “But if you ask the same questions again and again, or a couple times in a different way, you know you begin to get a sense of the candidate,” Esman said.

He believes that interviewers need to be willing to be a little more probing and they can’t leave the interview with questions unanswered. In some cases he thinks that virtual interviews can work in everyone’s favor, “Sometimes the candidates are more comfortable in their natural environments and they might actually be more forthcoming, because they’re in their natural environment. I asked another one of my partners today, like do you think it’s a better thing or a worse thing for virtual? And he said, ‘You know, I get more out of a virtual interview because the candidate is in their relaxed state’,” Esman said.

Catch up on previous episodes of I Don’t Care with Kevin Stevenson!

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More